https://www.selleckchem.com/pr....oducts/kd025-(slx-21
Most patients with pancreatic cancer have non-resectable disease at the time of diagnosis and usually die within 6-12 months. Despite indications in other solid tumors, the role of immunotherapy (IO) is unknown for late stage, advanced pancreatic cancer. Using the National Cancer Database (NCD, cases of Stage IV pancreatic cancers diagnosed in the period of 2014-2016 with at least 30-day follow up were retrospectively analyzed. The following clinical demographics were included age (younger than 70 . older than 7, sex (male
Like
Comment
Share
